Difficulty: Medium
Average Score: 86%
Practice
While looking through the chart of an infant with a congenital heart defect (CHD) of decreased pulmonary blood flow, the nurse would expect which laboratory finding?
Correct answer
D
Rationale
The correct answer is D) Polycythemia. In infants with a congenital heart defect (CHD) of decreased pulmonary blood flow, such as Tetralogy of Fallot, there is a right-to-left shunting of blood leading to decreased oxygen saturation in the systemic circulation. This chronic hypoxemia stimulates erythropoiesis, resulting in an increased production of red blood cells, hence causing polycythemia. This compensatory mechanism helps enhance oxygen-carrying capacity in the blood to address the reduced oxygen levels.
Regarding why the other options are incorrect:
A) Decreased platelet count: Platelet count is not typically affected in infants with CHD of decreased pulmonary blood flow. Platelet count alterations are more commonly associated with conditions like thrombocytopenia or thrombocytosis, which are not directly related to this type of CHD.
B) Decreased ferritin level: Ferritin is a marker of iron storage in the body. In the context of decreased pulmonary blood flow, there is no direct relationship between the defect and a decrease in ferritin levels. Iron status may be affected in certain types of anemia but not specifically in this scenario.
C) Respiratory alkalosis: While respiratory alkalosis can occur in infants with CHD due to increased respiratory rate to compensate for hypoxemia, it is not the laboratory finding directly associated with decreased pulmonary blood flow. Respiratory alkalosis is a result of hyperventilation and would be a clinical manifestation rather than a laboratory finding.
Educational context:
Understanding laboratory findings in pediatric cardiovascular disorders is crucial for nurses caring for infants with CHDs. Recognizing the implications of these findings helps in early identification of complications and appropriate intervention. In the case of decreased pulmonary blood flow, recognizing polycythemia as a potential laboratory finding aids in comprehensive patient assessment and management. Regular monitoring of laboratory values is essential to assess the effectiveness of treatment and the overall health status of infants with CHDs.
Regarding why the other options are incorrect:
A) Decreased platelet count: Platelet count is not typically affected in infants with CHD of decreased pulmonary blood flow. Platelet count alterations are more commonly associated with conditions like thrombocytopenia or thrombocytosis, which are not directly related to this type of CHD.
B) Decreased ferritin level: Ferritin is a marker of iron storage in the body. In the context of decreased pulmonary blood flow, there is no direct relationship between the defect and a decrease in ferritin levels. Iron status may be affected in certain types of anemia but not specifically in this scenario.
C) Respiratory alkalosis: While respiratory alkalosis can occur in infants with CHD due to increased respiratory rate to compensate for hypoxemia, it is not the laboratory finding directly associated with decreased pulmonary blood flow. Respiratory alkalosis is a result of hyperventilation and would be a clinical manifestation rather than a laboratory finding.
Educational context:
Understanding laboratory findings in pediatric cardiovascular disorders is crucial for nurses caring for infants with CHDs. Recognizing the implications of these findings helps in early identification of complications and appropriate intervention. In the case of decreased pulmonary blood flow, recognizing polycythemia as a potential laboratory finding aids in comprehensive patient assessment and management. Regular monitoring of laboratory values is essential to assess the effectiveness of treatment and the overall health status of infants with CHDs.